Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: Therapeutic implications for hemolytic-uremic syndrome

Glen D. Armstrong, George L. Mulvey, Paola Marcato, Thomas P. Griener, Melvyn C. Kahan, Glenys A. Tennent, Caroline A. Sabin, Henrik Chart, Mark B. Pepys

科研成果: 期刊稿件文章同行评审

38 引用 (Scopus)
源语言英语
页(从-至)1120-1124
页数5
期刊Journal of Infectious Diseases
193
8
DOI
出版状态已出版 - 4月 15 2006

!!!ASJC Scopus Subject Areas

  • 免疫学和过敏症
  • 传染病学

指纹

探究 'Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: Therapeutic implications for hemolytic-uremic syndrome' 的科研主题。它们共同构成独一无二的指纹。

引用此

Armstrong, G. D., Mulvey, G. L., Marcato, P., Griener, T. P., Kahan, M. C., Tennent, G. A., Sabin, C. A., Chart, H., & Pepys, M. B. (2006). Human serum amyloid P component protects against Escherichia coli O157:H7 shiga toxin 2 in vivo: Therapeutic implications for hemolytic-uremic syndrome. Journal of Infectious Diseases, 193(8), 1120-1124. https://doi.org/10.1086/501472